Provision of methadone treatment in primary care medical practices - Review of the Scottish experience and implications for US policy

Citation
M. Weinrich et M. Stuart, Provision of methadone treatment in primary care medical practices - Review of the Scottish experience and implications for US policy, J AM MED A, 283(10), 2000, pp. 1343-1348
Citations number
54
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
ISSN journal
00987484 → ACNP
Volume
283
Issue
10
Year of publication
2000
Pages
1343 - 1348
Database
ISI
SICI code
0098-7484(20000308)283:10<1343:POMTIP>2.0.ZU;2-V
Abstract
Context Under new proposed regulations, US physicians outside of traditiona l methadone clinics could prescribe methadone to patients with opioid depen dence. No large-scale evaluations of US programs in which methadone mainten ance is provided by primary care physicians are available, but primary care physicians in Scotland have participated in such programs on a large scale . Objective To review the history, operation, and outcome data on the efficac y and safety of 2 Scottish primary care-based opioid agonist treatment prog rams to derive lessons for the US context. Design and Setting Naturalistic study of programs in Edinburgh and Glasgow, Scotland, with data obtained through site visits and interviews conducted in 1996 and 1998, as well as from published reports and retrospective analy sis of electronic databases. Main Outcome Measures Proportions of injection drug users who were enrolled in the methadone maintenance programs, average methadone doses in the pro grams, and methadone-related deaths. Results A total of 60% to 80% of injection drug users in Edinburgh and 41% to 73% of those in Glasgow were enrolled in methadone maintenance in 1998-1 999, Dose levels are consistent with US recommendations (for Edinburgh in 1 998, 61 mg; for Glasgow in 1994-1996, 54 mg). The Glasgow program required supervised consumption of methadone in community pharmacies for the first y ear and experienced significantly fewer methadone-related deaths than Edinb urgh in 1997 (17 vs 30 deaths; P<.0001). Programs in both Edinburgh and Gla sgow provided support to primary care physicians and achieved levels of gen eral practitioner participation of 59% (1998) and 30% (1999), respectively. Conclusions The Scottish experience indicates that prescription of methadon e in office-based settings can expand access to an important treatment moda lity. Primary care physicians safely prescribed methadone for maintenance t reatment when provided with adequate support. Diversion of methadone was mi nimized by requiring supervised consumption in community pharmacies.